Seed: Vida agent + health domain -- 40 claims #15
42 changed files with 132 additions and 131 deletions
|
|
@ -11,6 +11,7 @@ You are an agent in the Teleo collective — a group of AI domain specialists th
|
|||
| **Leo** | Grand strategy / cross-domain | Everything — coordinator | **Evaluator** — reviews all PRs, synthesizes cross-domain |
|
||||
| **Rio** | Internet finance | `domains/internet-finance/` | **Proposer** — extracts and proposes claims |
|
||||
| **Clay** | Entertainment / cultural dynamics | `domains/entertainment/` | **Proposer** — extracts and proposes claims |
|
||||
| **Vida** | Health & human flourishing | `domains/health/` | **Proposer** — extracts and proposes claims |
|
||||
|
||||
## Repository Structure
|
||||
|
||||
|
|
|
|||
|
|
@ -18,10 +18,10 @@ The critical question is whether AI can move the needle beyond Phase I. The phar
|
|||
---
|
||||
|
||||
Relevant Notes:
|
||||
- [[recursive improvement is the engine of human progress because we get better at getting better]] -- AI drug discovery is recursive improvement applied to pharma R&D
|
||||
- recursive improvement is the engine of human progress because we get better at getting better -- AI drug discovery is recursive improvement applied to pharma R&D
|
||||
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] -- new drugs from AI discovery feed into the monitoring-driven care model
|
||||
- [[clinical trials should use adaptive allocation to minimize harm to patients during the trial not just produce clean data for future patients]] -- adaptive trial designs could improve the 90% clinical failure rate by reallocating patients away from failing arms mid-trial rather than running fixed protocols to completion
|
||||
- clinical trials should use adaptive allocation to minimize harm to patients during the trial not just produce clean data for future patients -- adaptive trial designs could improve the 90% clinical failure rate by reallocating patients away from failing arms mid-trial rather than running fixed protocols to completion
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -22,5 +22,5 @@ Relevant Notes:
|
|||
- [[AI middleware bridges consumer wearable data to clinical utility because continuous data is too voluminous for direct clinician review]] -- the same AI middleware pattern applies to clinical imaging data
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -24,5 +24,5 @@ Relevant Notes:
|
|||
- [[centaur teams outperform both pure humans and pure AI because complementary strengths compound]] -- the monitoring centaur: AI handles volume, humans provide judgment
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -32,10 +32,10 @@ This data powerfully validates [[the epidemiological transition marks the shift
|
|||
|
||||
Relevant Notes:
|
||||
- [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]] -- the US life expectancy reversal is the most dramatic empirical confirmation of this claim
|
||||
- [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]] -- 75 percent of US healthcare dollars go to preventable diseases while government subsidizes the behaviors causing them
|
||||
- [[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]] -- deaths of despair are the most extreme symptom of a system that profits from treating rather than preventing
|
||||
- healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured -- 75 percent of US healthcare dollars go to preventable diseases while government subsidizes the behaviors causing them
|
||||
- US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health -- deaths of despair are the most extreme symptom of a system that profits from treating rather than preventing
|
||||
- [[the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access]] -- mental health is both a driver of deaths of despair and itself worsened by the same economic forces
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[livingip overview]]
|
||||
- health and wellness
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -32,11 +32,11 @@ The four major risk factors behind the highest burden of noncommunicable disease
|
|||
Relevant Notes:
|
||||
- [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]] -- the transition created the conditions under which noncommunicable diseases could eclipse infectious ones
|
||||
- [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]] -- deaths of despair and diet-driven chronic disease are parallel products of the same economic forces
|
||||
- [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]] -- 75 percent of healthcare spending goes to preventable diseases, many diet-related
|
||||
- [[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]] -- the pharmaceutical approach to diet-driven disease is the epitome of treating symptoms not causes
|
||||
- healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured -- 75 percent of healthcare spending goes to preventable diseases, many diet-related
|
||||
- US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health -- the pharmaceutical approach to diet-driven disease is the epitome of treating symptoms not causes
|
||||
- [[the clockwork universe paradigm built effective industrial systems by assuming stability and reducibility but fails when interdependence makes small causes produce disproportionate effects]] -- reductionist medicine treats the body as separable clockwork rather than an interdependent complex system
|
||||
- [[specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially]] -- the same autocatalytic specialization that ended famine now drives the chronic disease epidemic
|
||||
- specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially -- the same autocatalytic specialization that ended famine now drives the chronic disease epidemic
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[livingip overview]]
|
||||
- health and wellness
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -24,7 +24,7 @@ The arbitrage works in two steps:
|
|||
|
||||
**Legal status:** The MLR gaming itself occupies a regulatory gray zone -- exploiting a gap in ACA rules written before the current wave of vertical integration. No one has been charged specifically for transfer pricing arbitrage. However, DOJ has active antitrust and criminal investigations into UnitedHealth (opened February 2024), examining both Optum acquisitions and Medicare billing practices. Congressional response is escalating: the Patients Over Profits Act (September 2025, Ryan/Warren) would ban insurers from owning medical practices entirely; the Break Up Big Medicine Act (Warren/Hawley, 2026) would impose Glass-Steagall-style structural separation. UnitedHealth "strongly refuted" the Health Affairs findings, calling the data "cherry-picked" and arguing they pay Optum "consistent with other providers in the market."
|
||||
|
||||
The broader 2027 rate environment compounds the pressure into a three-pronged squeeze: the net payment rate increase is essentially flat at 0.09% (Wall Street had built 4-6% increases into models), far below medical cost trends. V28 risk adjustment is fully phased in for 2026, and CMS proposes recalibrating using 2023 diagnoses to predict 2024 costs, which would reduce MA risk scores by 3.32% relative to 2026. Additionally, CMS proposes **Star Ratings redesign** shifting from administrative/process metrics toward member experience and clinical outcomes -- further disadvantaging incumbents whose quality scores depend on paperwork-based categories and rewarding plans like Devoted and Kaiser with genuine member experience excellence. Incumbent insurer stocks fell 9-13% on the Advance Notice announcement; UnitedHealth dropped an additional ~20% on compounding Optum earnings losses and reduced growth guidance. Multiple large insurers have already replaced CEOs and leadership teams specifically to restore profitability. Since [[CMS 2027 rate notice creates a three-pronged regulatory squeeze that forces incumbents into margin-protection retreat while Devoteds 9-point cost advantage enables continued growth]], the chart review exclusion is one component of a coordinated regulatory strategy, not an isolated policy change.
|
||||
The broader 2027 rate environment compounds the pressure into a three-pronged squeeze: the net payment rate increase is essentially flat at 0.09% (Wall Street had built 4-6% increases into models), far below medical cost trends. V28 risk adjustment is fully phased in for 2026, and CMS proposes recalibrating using 2023 diagnoses to predict 2024 costs, which would reduce MA risk scores by 3.32% relative to 2026. Additionally, CMS proposes **Star Ratings redesign** shifting from administrative/process metrics toward member experience and clinical outcomes -- further disadvantaging incumbents whose quality scores depend on paperwork-based categories and rewarding plans like Devoted and Kaiser with genuine member experience excellence. Incumbent insurer stocks fell 9-13% on the Advance Notice announcement; UnitedHealth dropped an additional ~20% on compounding Optum earnings losses and reduced growth guidance. Multiple large insurers have already replaced CEOs and leadership teams specifically to restore profitability. Since CMS 2027 rate notice creates a three-pronged regulatory squeeze that forces incumbents into margin-protection retreat while Devoteds 9-point cost advantage enables continued growth, the chart review exclusion is one component of a coordinated regulatory strategy, not an isolated policy change.
|
||||
|
||||
**Who gets hurt:** Plans that generate significant revenue from retrospective coding rather than genuine clinical encounters. UnitedHealth and Humana, with the largest owned provider networks and the most aggressive chart review programs, face disproportionate impact. UnitedHealth already expects to lose 1 million MA members in 2026 from repricing; the chart review exclusion would further erode the economics of their vertical integration model.
|
||||
|
||||
|
|
@ -41,7 +41,7 @@ Relevant Notes:
|
|||
- [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] -- UHC's vertical integration arbitrage is the proxy being removed by CMS
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- CMS is tightening the FFS-to-VBC transition by closing profitable FFS-like mechanisms within MA
|
||||
- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening]] -- CMS tightening specifically advantages Devoted's purpose-built model
|
||||
- [[five guideposts predict industry transitions -- rising fixed costs force consolidation and deregulation unwinds cross-subsidies creating cream-skimming opportunities]] -- CMS chart review exclusion is a regulatory intervention that unwinds the cross-subsidy from upcoded risk scores
|
||||
- five guideposts predict industry transitions -- rising fixed costs force consolidation and deregulation unwinds cross-subsidies creating cream-skimming opportunities -- CMS chart review exclusion is a regulatory intervention that unwinds the cross-subsidy from upcoded risk scores
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -34,4 +34,4 @@ Relevant Notes:
|
|||
- [[anti-payvidor legislation targets all insurer-provider integration without distinguishing acquisition-based arbitrage from purpose-built care delivery]] -- the regulatory risk that could affect Devoted despite its structural differentiation
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -29,10 +29,10 @@ The platform has significant expansion potential. Since [[continuous health moni
|
|||
|
||||
Relevant Notes:
|
||||
- [[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]] -- Function Health is the purest expression of atoms-to-bits strategy at the diagnostics conversion point
|
||||
- [[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]] -- Function's outcomes-aligned model parallels Devoted's approach at the diagnostics conversion point
|
||||
- Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them -- Function's outcomes-aligned model parallels Devoted's approach at the diagnostics conversion point
|
||||
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] -- Function could integrate continuous wearable data between periodic lab tests
|
||||
- [[value in industry transitions accrues to bottleneck positions in the emerging architecture not to pioneers or to the largest incumbents]] -- diagnostics is a bottleneck position in healthcare's emerging architecture
|
||||
- [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] -- Quest and Labcorp won't cannibalize their $100+ per test pricing to match Function's $5/test economics
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -25,4 +25,4 @@ Relevant Notes:
|
|||
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] -- biometric monitoring could identify GLP-1 candidates earlier and track metabolic response
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -39,9 +39,9 @@ Since [[four competing payer-provider models are converging toward value-based c
|
|||
Relevant Notes:
|
||||
- [[anti-payvidor legislation targets all insurer-provider integration without distinguishing acquisition-based arbitrage from purpose-built care delivery]] -- the legislation Kaiser's precedent provides defense against
|
||||
- [[four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable]] -- Kaiser is the Consumer Health Partner model, the longest-running payvidor
|
||||
- [[Devoted faces low-probability but existential regulatory risk from structural separation bills that would require divesting Devoted Medical within one to two years]] -- Kaiser's precedent directly supports Devoted's differentiation arguments
|
||||
- Devoted faces low-probability but existential regulatory risk from structural separation bills that would require divesting Devoted Medical within one to two years -- Kaiser's precedent directly supports Devoted's differentiation arguments
|
||||
- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] -- CMS mechanism-targeting is the alternative to structural separation, and Kaiser's FCA settlement shows existing enforcement works
|
||||
|
||||
Topics:
|
||||
- [[devoted overview]]
|
||||
- [[health and wellness]]
|
||||
- devoted overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -24,5 +24,5 @@ Relevant Notes:
|
|||
- [[knowledge scaling bottlenecks kill revolutionary ideas before they reach critical mass]] -- OpenEvidence solved clinical knowledge scaling by making evidence retrieval instant
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -38,5 +38,5 @@ Relevant Notes:
|
|||
- [[Function Health drives down diagnostic conversion costs to 499 per year for 100-plus lab tests making atoms-to-bits health data generation accessible at consumer scale]] -- Function could bundle wearable monitoring with diagnostics, commoditizing standalone rings
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[livingip overview]]
|
||||
- health and wellness
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -25,4 +25,4 @@ Relevant Notes:
|
|||
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] -- biometric monitoring addresses clinical SDOH (sleep, activity) but not social SDOH (housing, food)
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -33,5 +33,5 @@ Relevant Notes:
|
|||
- [[Function Health drives down diagnostic conversion costs to 499 per year for 100-plus lab tests making atoms-to-bits health data generation accessible at consumer scale]] -- WHOOP's Advanced Labs (blood testing via Quest) competes directly with Function's diagnostics model but from a weaker starting position
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[livingip overview]]
|
||||
- health and wellness
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -65,14 +65,14 @@ Vida's domain spans the structural transformation of healthcare from reactive si
|
|||
## Demand Signals (claims referenced but not yet written)
|
||||
|
||||
**Devoted Health-specific** (highest priority — Cory works at TSB which led Devoted's Series F and F-Prime):
|
||||
- `[[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]]`
|
||||
- `[[Devoteds Orinoco platform eliminates healthcare data silos by building a unified AI-native operating system from scratch rather than assembling from legacy components]]`
|
||||
- `[[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]]`
|
||||
- `[[UnitedHealth and Humana exhibit textbook proxy inertia where coding arbitrage profits rationally prevent pursuit of purpose-built care delivery]]`
|
||||
- `Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate`
|
||||
- `Devoteds Orinoco platform eliminates healthcare data silos by building a unified AI-native operating system from scratch rather than assembling from legacy components`
|
||||
- `Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them`
|
||||
- `UnitedHealth and Humana exhibit textbook proxy inertia where coding arbitrage profits rationally prevent pursuit of purpose-built care delivery`
|
||||
|
||||
**Structural health claims** (needed to complete reasoning chains):
|
||||
- `[[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]]`
|
||||
- `[[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]]`
|
||||
- `US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health`
|
||||
- `healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured`
|
||||
|
||||
**Known thin areas**:
|
||||
- GLP-1 economics beyond launch — durability/adherence problem, second-generation oral formulations
|
||||
|
|
|
|||
|
|
@ -26,5 +26,5 @@ Relevant Notes:
|
|||
- [[the physician role shifts from information processor to relationship manager as AI automates documentation triage and evidence synthesis]] -- ambient docs are the mechanism enabling this role shift
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -46,10 +46,10 @@ Relevant Notes:
|
|||
- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] -- CMS mechanism-targeting is the alternative to legislative structural separation and is already further along
|
||||
- [[four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable]] -- both bills would reshape the competitive landscape by banning the Integrated Behemoth and Aligned Partner models equally
|
||||
- [[Kaiser Permanentes 80-year tripartite structure is the strongest precedent for purpose-built payvidor exemptions because any structural separation bill that captures Kaiser faces 12.5 million members and Californias entire healthcare infrastructure]] -- the exemption precedent that could protect purpose-built payvidors
|
||||
- [[Devoted faces low-probability but existential regulatory risk from structural separation bills that would require divesting Devoted Medical within one to two years]] -- Devoted-specific impact assessment
|
||||
- Devoted faces low-probability but existential regulatory risk from structural separation bills that would require divesting Devoted Medical within one to two years -- Devoted-specific impact assessment
|
||||
- [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] -- UHG lobbying to preserve the status quo is proxy inertia that paradoxically also protects purpose-built competitors
|
||||
- [[five guideposts predict industry transitions -- rising fixed costs force consolidation and deregulation unwinds cross-subsidies creating cream-skimming opportunities]] -- the anti-payvidor bills represent re-regulation that would unwind the vertical integration consolidation wave
|
||||
- five guideposts predict industry transitions -- rising fixed costs force consolidation and deregulation unwinds cross-subsidies creating cream-skimming opportunities -- the anti-payvidor bills represent re-regulation that would unwind the vertical integration consolidation wave
|
||||
|
||||
Topics:
|
||||
- [[devoted overview]]
|
||||
- [[health and wellness]]
|
||||
- devoted overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -24,5 +24,5 @@ Relevant Notes:
|
|||
- [[Oura controls 80 percent of the smart ring market with patent-defended form factor while a demographic pivot from fitness enthusiasts to wellness-focused women drives 250 percent sales growth]] -- Oura's Veri acquisition positions it to integrate CGM data into its ring platform, bridging Layer 1 and Layer 2
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -27,5 +27,5 @@ Relevant Notes:
|
|||
- [[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]] -- the wearable sensor stack is atoms-to-bits conversion infrastructure; value accrues at the physical-digital interface, not the software layer
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -24,19 +24,19 @@ The extraordinary development is that increasing economic specialization has eff
|
|||
- **Epidemic disease:** Pneumonia is the only infectious disease still among the leading causes of death in developed nations, and usually as a complication of underlying chronic disease. Life expectancy rose from ~30 years globally in 1800 to ~73 in 2019.
|
||||
- **Large-scale war:** Increasing specialization made wealth knowledge-based rather than resource-based, making conquest economically irrational among developed nations. War is now concentrated in regions where wealth is still primarily embodied in physical assets.
|
||||
|
||||
But the same specialization that solved these ancient problems created an entirely new risk landscape. Since [[existential risk breaks trial and error because the first failure is the last event]], the new risks -- nuclear weapons, climate change, AI, bioengineering -- are products of the extreme specialization that defeated famine, disease, and war. Since [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]], the individual health burden has shifted from infectious disease to chronic noncommunicable disease and mental health crises. The solutions to the old problems are the sources of the new ones.
|
||||
But the same specialization that solved these ancient problems created an entirely new risk landscape. Since existential risk breaks trial and error because the first failure is the last event, the new risks -- nuclear weapons, climate change, AI, bioengineering -- are products of the extreme specialization that defeated famine, disease, and war. Since [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]], the individual health burden has shifted from infectious disease to chronic noncommunicable disease and mental health crises. The solutions to the old problems are the sources of the new ones.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- [[existential risk breaks trial and error because the first failure is the last event]] -- the new risk landscape created by specialization permits no second chances, unlike the old one
|
||||
- existential risk breaks trial and error because the first failure is the last event -- the new risk landscape created by specialization permits no second chances, unlike the old one
|
||||
- [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]] -- the individual-health analog of this civilizational-risk shift
|
||||
- [[specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially]] -- specialization is the single force that both solved the old risks and created the new ones
|
||||
- specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially -- specialization is the single force that both solved the old risks and created the new ones
|
||||
- [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]] -- the US life expectancy reversal is the most visible symptom of the new risk landscape
|
||||
- [[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]] -- the noncommunicable disease epidemic is the food-system instance of the new risk landscape replacing the old
|
||||
- [[capital reallocation toward civilizational problem-solving is autocatalytic because excess returns attract more capital]] -- solving the new risk landscape creates the same autocatalytic dynamic that solved the old one but now requires deliberate direction rather than trial and error
|
||||
- capital reallocation toward civilizational problem-solving is autocatalytic because excess returns attract more capital -- solving the new risk landscape creates the same autocatalytic dynamic that solved the old one but now requires deliberate direction rather than trial and error
|
||||
|
||||
Topics:
|
||||
- [[historical transitions]]
|
||||
- [[health and wellness]]
|
||||
- [[livingip overview]]
|
||||
- historical transitions
|
||||
- health and wellness
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -25,13 +25,13 @@ These four organizations plus subsidiaries comprised 70% of terminated MA plan m
|
|||
|
||||
Relevant Notes:
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- the VBC transition these models compete to deliver
|
||||
- [[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]] -- Devoted's specific competitive position within the aligned partner model
|
||||
- Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them -- Devoted's specific competitive position within the aligned partner model
|
||||
- [[healthcare is a complex adaptive system requiring simple enabling rules not complicated management because standardized processes erode the clinical autonomy needed for value creation]] -- the aligned partner model preserves clinician autonomy that vertical integration may erode
|
||||
- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] -- CMS regulation specifically targeting the Integrated Behemoth model's coding arbitrage, which may accelerate the shift toward aligned partnership
|
||||
- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening]] -- competitive evidence: Devoted growing 121% while UHC sheds 1M members and Humana faces $3.5B star headwind
|
||||
- [[Devoteds Orinoco platform eliminates healthcare data silos by building a unified AI-native operating system from scratch rather than assembling from legacy components]] -- the technology architecture enabling the aligned partner model: purpose-built integration vs assembled-through-acquisition integration
|
||||
- Devoteds Orinoco platform eliminates healthcare data silos by building a unified AI-native operating system from scratch rather than assembling from legacy components -- the technology architecture enabling the aligned partner model: purpose-built integration vs assembled-through-acquisition integration
|
||||
- [[anti-payvidor legislation targets all insurer-provider integration without distinguishing acquisition-based arbitrage from purpose-built care delivery]] -- both proposed bills would ban the Integrated Behemoth and Aligned Partner models equally, failing to distinguish the structural abuse from the structural benefit
|
||||
- [[Kaiser Permanentes 80-year tripartite structure is the strongest precedent for purpose-built payvidor exemptions because any structural separation bill that captures Kaiser faces 12.5 million members and Californias entire healthcare infrastructure]] -- Kaiser's Consumer Health Partner model is the strongest precedent for preserving purpose-built integration through regulatory cycles
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -25,4 +25,4 @@ Relevant Notes:
|
|||
- [[AI compresses drug discovery timelines by 30-40 percent but has not yet improved the 90 percent clinical failure rate that determines industry economics]] -- AI accelerates target identification but gene editing provides the delivery mechanism for curative interventions
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -29,4 +29,4 @@ Relevant Notes:
|
|||
- [[performance overshooting creates a vacuum for good-enough alternatives when products exceed what mainstream customers need]] -- AI diagnostic accuracy already exceeds physician performance on benchmarks, yet outcomes barely improve, suggesting the bottleneck is not accuracy but system integration
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -29,4 +29,4 @@ Relevant Notes:
|
|||
- [[WHOOP subscription-only wearable model generates $260M revenue but trails Oura at half the revenue and a third the valuation because fitness-first positioning limits the addressable wellness market]] -- WHOOP's 4+ year fundraising gap illustrates the other side: companies that miss the capital wave face stale valuations
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -22,8 +22,8 @@ The AI payment problem compounds the regulatory gap. No payer currently reimburs
|
|||
Relevant Notes:
|
||||
- [[the FDA now separates wellness devices from medical devices based on claims not sensor technology enabling health insights without full medical device classification]] -- the FDA has already created flexibility for wellness devices; clinical AI needs a parallel regulatory innovation
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- AI payment gaps may accelerate VBC adoption by making fee-for-service untenable for AI-enabled care
|
||||
- [[adaptive governance outperforms rigid alignment blueprints because superintelligence development has too many unknowns for fixed plans]] -- the same principle applies to clinical AI: governance frameworks must adapt with the technology
|
||||
- adaptive governance outperforms rigid alignment blueprints because superintelligence development has too many unknowns for fixed plans -- the same principle applies to clinical AI: governance frameworks must adapt with the technology
|
||||
- [[technology advances exponentially but coordination mechanisms evolve linearly creating a widening gap]] -- healthcare AI regulation is a specific instance of this general coordination gap
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -26,14 +26,14 @@ Relevant Notes:
|
|||
- [[Hayek argued that designed rules of just conduct enable spontaneous order of greater complexity than deliberate arrangement could achieve]] -- healthcare's complexity exceeds any central planner's capacity, requiring Hayekian spontaneous order within designed rules
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- the current state of the VBC transition this framework aims to accelerate
|
||||
|
||||
- [[space settlement governance must be designed before settlements exist because retroactive governance of autonomous communities is historically impossible]] -- both healthcare and space governance must provide enabling constraints not prescriptive rules, and both face the challenge of designing governance before the system fully exists
|
||||
- [[chain-link systems get stuck at low-effectiveness equilibria because improving any single link produces no visible gain until all links improve]] -- healthcare delivery as a chain-link system where piecemeal improvement at individual links fails
|
||||
- [[excellence in chain-link systems creates durable competitive advantage because a competitor must match every link simultaneously]] -- the flip side: healthcare organizations that achieve chain-link excellence create nearly unreplicable advantages
|
||||
- space settlement governance must be designed before settlements exist because retroactive governance of autonomous communities is historically impossible -- both healthcare and space governance must provide enabling constraints not prescriptive rules, and both face the challenge of designing governance before the system fully exists
|
||||
- chain-link systems get stuck at low-effectiveness equilibria because improving any single link produces no visible gain until all links improve -- healthcare delivery as a chain-link system where piecemeal improvement at individual links fails
|
||||
- excellence in chain-link systems creates durable competitive advantage because a competitor must match every link simultaneously -- the flip side: healthcare organizations that achieve chain-link excellence create nearly unreplicable advantages
|
||||
|
||||
- [[diagnosis is the most undervalued element of strategy because naming the challenge correctly simplifies overwhelming complexity into a problem that can be addressed]] -- the CAS diagnosis of healthcare IS a Rumelt-style re-diagnosis: most reform treats healthcare as a complicated system requiring better management; the CAS diagnosis reframes it as a complex system requiring enabling rules, which transforms the entire strategy
|
||||
- [[the resource-design tradeoff means organizations with fewer resources must compensate with tighter strategic coherence]] -- value-based care organizations that achieve tighter coherence between measurement, incentives, and governance outperform better-resourced fee-for-service systems with looser strategic coordination
|
||||
- diagnosis is the most undervalued element of strategy because naming the challenge correctly simplifies overwhelming complexity into a problem that can be addressed -- the CAS diagnosis of healthcare IS a Rumelt-style re-diagnosis: most reform treats healthcare as a complicated system requiring better management; the CAS diagnosis reframes it as a complex system requiring enabling rules, which transforms the entire strategy
|
||||
- the resource-design tradeoff means organizations with fewer resources must compensate with tighter strategic coherence -- value-based care organizations that achieve tighter coherence between measurement, incentives, and governance outperform better-resourced fee-for-service systems with looser strategic coordination
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[emergence and complexity]]
|
||||
- [[coordination mechanisms]]
|
||||
- health and wellness
|
||||
- emergence and complexity
|
||||
- coordination mechanisms
|
||||
|
|
|
|||
|
|
@ -24,26 +24,26 @@ Software is getting easier. AI capabilities are commoditizing. You cannot build
|
|||
|
||||
The trust dimension is as important as the data dimension. Devoted's prime directive is "Treat Everyone Like Family" -- a standing order that empowers any team member to take action without permission by imagining a loved family member's face and doing what they'd do for their own family. Function Health's brand has cultivated deep consumer trust. In healthcare, people are trusting you with their bodies and their lives. That trust compounds at physical touchpoints in ways that pure software interfaces cannot replicate. Corporate culture and brand trust are soft moats that harden over time because they are difficult to fake and impossible to acquire.
|
||||
|
||||
This framing explains Zachary Werner's investment strategy. Since [[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]], Devoted controls the clinical encounter conversion point. Werner sits on Function Health's board, which controls the diagnostics conversion point. VZVC investing in Devoted while Werner co-started Function isn't diversification. It's the same atoms-to-bits thesis expressed at two different conversion points, unified by the same belief: financial outcomes should align with health outcomes.
|
||||
This framing explains Zachary Werner's investment strategy. Since Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them, Devoted controls the clinical encounter conversion point. Werner sits on Function Health's board, which controls the diagnostics conversion point. VZVC investing in Devoted while Werner co-started Function isn't diversification. It's the same atoms-to-bits thesis expressed at two different conversion points, unified by the same belief: financial outcomes should align with health outcomes.
|
||||
|
||||
The three-layer model for the healthcare attractor state:
|
||||
1. **Purpose layer** -- Consumer-centric care. Treat everyone like family. Build trust that compounds.
|
||||
2. **Scale layer** -- Software makes it scalable. AI diagnostics, virtual care coordination, continuous optimization.
|
||||
3. **Defense layer** -- Atoms-to-bits conversion generates the data and builds the trust that software alone cannot replicate.
|
||||
|
||||
Since [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]], the wearable sensor stack represents another tier of atoms-to-bits conversion infrastructure. Since [[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]], Devoted is the fullest expression of this thesis at the care delivery level.
|
||||
Since [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]], the wearable sensor stack represents another tier of atoms-to-bits conversion infrastructure. Since Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate, Devoted is the fullest expression of this thesis at the care delivery level.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- [[value in industry transitions accrues to bottleneck positions in the emerging architecture not to pioneers or to the largest incumbents]] -- atoms-to-bits conversion IS the bottleneck position in healthcare's emerging architecture
|
||||
- [[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]] -- the alignment between health outcomes and financial outcomes is what makes the consumer-centric strategy self-reinforcing
|
||||
- [[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]] -- Devoted is the fullest expression of the atoms-to-bits thesis at the care delivery level
|
||||
- Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them -- the alignment between health outcomes and financial outcomes is what makes the consumer-centric strategy self-reinforcing
|
||||
- Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate -- Devoted is the fullest expression of the atoms-to-bits thesis at the care delivery level
|
||||
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] -- the wearable sensor stack is another tier of atoms-to-bits conversion infrastructure
|
||||
- [[competitive advantage must be actively deepened through isolating mechanisms because advantage that is not reinforced erodes]] -- trust and data flywheel are the isolating mechanisms that deepen the atoms-to-bits moat over time
|
||||
- competitive advantage must be actively deepened through isolating mechanisms because advantage that is not reinforced erodes -- trust and data flywheel are the isolating mechanisms that deepen the atoms-to-bits moat over time
|
||||
- [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] -- incumbents won't drive down diagnostic costs because current margins are profitable
|
||||
- [[prescription digital therapeutics failed as a business model because FDA clearance creates regulatory cost without the pricing power that justifies it for near-zero marginal cost software]] -- pure software plays in healthcare fail precisely because the defensible layer is atoms, not bits
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[attractor dynamics]]
|
||||
- health and wellness
|
||||
- attractor dynamics
|
||||
|
|
|
|||
|
|
@ -26,7 +26,7 @@ Relevant Notes:
|
|||
- [[medical LLM benchmark performance does not translate to clinical impact because physicians with and without AI access achieve similar diagnostic accuracy in randomized trials]] -- the multi-hospital RCT found similar diagnostic accuracy with/without AI; the Stanford/Harvard study found AI alone dramatically superior
|
||||
- [[the physician role shifts from information processor to relationship manager as AI automates documentation triage and evidence synthesis]] -- if physicians degrade AI diagnostic performance, the role shift toward relationship management is not just efficient but necessary
|
||||
- [[ambient AI documentation reduces physician documentation burden by 73 percent but the relationship between automation and burnout is more complex than time savings alone]] -- documentation AI where physicians don't override outputs avoids the de-skilling problem
|
||||
- [[emergent misalignment arises naturally from reward hacking as models develop deceptive behaviors without any training to deceive]] -- human-in-the-loop oversight is the standard safety measure against misalignment, but if humans reliably fail at oversight, this safety architecture is weaker than assumed
|
||||
- emergent misalignment arises naturally from reward hacking as models develop deceptive behaviors without any training to deceive -- human-in-the-loop oversight is the standard safety measure against misalignment, but if humans reliably fail at oversight, this safety architecture is weaker than assumed
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -25,5 +25,5 @@ Relevant Notes:
|
|||
- [[OpenEvidence became the fastest-adopted clinical technology in history reaching 40 percent of US physicians daily within two years]] -- OpenEvidence succeeds as evidence retrieval, not diagnostic replacement
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -35,9 +35,9 @@ Relevant Notes:
|
|||
- [[social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem]] -- loneliness is one of the most actionable SDOH factors with clear cost signature and robust evidence
|
||||
- [[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]] -- the 90% finding motivates SDOH intervention but the implementation gap persists
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- VBC is the payment model aligned with addressing non-clinical determinants but remains minority practice
|
||||
- [[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]] -- the misalignment is even deeper than clinical vs preventive -- it ignores the 80-90% of determinants that clinical care does not touch
|
||||
- US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health -- the misalignment is even deeper than clinical vs preventive -- it ignores the 80-90% of determinants that clinical care does not touch
|
||||
- [[healthcare is a complex adaptive system requiring simple enabling rules not complicated management because standardized processes erode the clinical autonomy needed for value creation]] -- addressing the full spectrum of determinants requires enabling rules, not standardized SDOH checklists
|
||||
- [[human needs are finite universal and stable across millennia making them the invariant constraints from which industry attractor states can be derived]] -- health needs are a subset of universal needs, and the attractor state must address the full spectrum not just clinical encounters
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -32,9 +32,9 @@ Relevant Notes:
|
|||
- [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]] -- the most dramatic empirical confirmation that modernization-without-community produces lethal outcomes
|
||||
- [[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]] -- food addiction is one vector; attention addiction via social media is another
|
||||
- [[the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access]] -- the supply gap exists because the problem is growing faster than the system designed to address it
|
||||
- [[specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially]] -- the same feedback loop that drives material progress also drives the psychosocial disconnection
|
||||
- specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially -- the same feedback loop that drives material progress also drives the psychosocial disconnection
|
||||
- [[a shared long-term goal transforms zero-sum conflicts into debates about methods]] -- shared goals may be the replacement structure for the community bonds that modernization dissolved
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[livingip overview]]
|
||||
- health and wellness
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -25,4 +25,4 @@ Relevant Notes:
|
|||
- [[AI compresses drug discovery timelines by 30-40 percent but has not yet improved the 90 percent clinical failure rate that determines industry economics]] -- AI-accelerated neoantigen selection is critical to scaling personalized vaccine manufacturing
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -26,4 +26,4 @@ Relevant Notes:
|
|||
- [[WHOOP subscription-only wearable model generates $260M revenue but trails Oura at half the revenue and a third the valuation because fitness-first positioning limits the addressable wellness market]] -- WHOOP's FDA defiance on blood pressure parallels DTx's cautionary tale: regulatory engagement without matching business model economics
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -24,10 +24,10 @@ Relevant Notes:
|
|||
- [[the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access]] -- loneliness compounds the mental health crisis through a mechanism (social infrastructure) that therapist supply alone cannot address
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- VBC is the payment mechanism that could justify social prescribing investment but it has not matured enough
|
||||
- [[prescription digital therapeutics failed as a business model because FDA clearance creates regulatory cost without the pricing power that justifies it for near-zero marginal cost software]] -- social prescribing operates outside the pharma reimbursement model that killed DTx
|
||||
- [[loneliness is a cause of depression that precedes it not a symptom that follows because humans evolved to need tribes]] -- source-faithful treatment of Hari's argument that loneliness is a causal driver of depression not merely a correlate, providing the psychological mechanism behind the Medicare cost data
|
||||
- [[social prescribing treats depression by reconnecting people to community activities rather than prescribing drugs]] -- source-faithful treatment of Hari's reporting on social prescribing as a clinical intervention, complementing the US policy and ROI data in this note with ground-level evidence from practitioners
|
||||
- loneliness is a cause of depression that precedes it not a symptom that follows because humans evolved to need tribes -- source-faithful treatment of Hari's argument that loneliness is a causal driver of depression not merely a correlate, providing the psychological mechanism behind the Medicare cost data
|
||||
- social prescribing treats depression by reconnecting people to community activities rather than prescribing drugs -- source-faithful treatment of Hari's reporting on social prescribing as a clinical intervention, complementing the US policy and ROI data in this note with ground-level evidence from practitioners
|
||||
- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] -- loneliness is among the most actionable of the 80-90% non-clinical factors, with $6.7B Medicare cost and WHO estimate of 871K deaths annually
|
||||
- [[Devoted democratizes VIP-level care by assigning every member a hybrid AI-human care team with digital twins and hundreds of daily interactions]] -- Devoted's care model explicitly includes loneliness reduction as a care function, addressing the $6.7B cost driver through persistent human+AI connection
|
||||
- Devoted democratizes VIP-level care by assigning every member a hybrid AI-human care team with digital twins and hundreds of daily interactions -- Devoted's care model explicitly includes loneliness reduction as a care function, addressing the $6.7B cost driver through persistent human+AI connection
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -19,10 +19,10 @@ This two-track system has structural implications. It lowers the barrier for get
|
|||
|
||||
Relevant Notes:
|
||||
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] -- the regulatory framework enabling the sensor stack to reach consumers
|
||||
- [[adaptive governance outperforms rigid alignment blueprints because superintelligence development has too many unknowns for fixed plans]] -- TEMPO's real-world evidence approach mirrors the adaptive governance principle
|
||||
- adaptive governance outperforms rigid alignment blueprints because superintelligence development has too many unknowns for fixed plans -- TEMPO's real-world evidence approach mirrors the adaptive governance principle
|
||||
- [[WHOOP subscription-only wearable model generates $260M revenue but trails Oura at half the revenue and a third the valuation because fitness-first positioning limits the addressable wellness market]] -- WHOOP MG blood pressure confrontation is the live test case for where wellness-medical boundary actually sits
|
||||
- [[Oura controls 80 percent of the smart ring market with patent-defended form factor while a demographic pivot from fitness enthusiasts to wellness-focused women drives 250 percent sales growth]] -- Oura stays firmly in wellness classification, strategically avoiding the medical device boundary WHOOP crossed
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -23,17 +23,17 @@ The mechanism is evolutionary. Our psychologies evolved under conditions of mate
|
|||
|
||||
This creates a profound paradox for economic development: a society can be absolutely better off in material terms while experiencing worse health outcomes, if growth is accompanied by widening inequality. The rising tide lifts all ships, but if it lifts some ships far more than others, the psychosocial damage can outweigh the material gains.
|
||||
|
||||
Since [[specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially]], the same specialization that drives economic growth also drives the inequality that undermines health. Since [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]], the epidemiological transition explains WHY healthcare costs escalate: the system is fighting psychosocially-driven disease with materialist medicine.
|
||||
Since specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially, the same specialization that drives economic growth also drives the inequality that undermines health. Since healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured, the epidemiological transition explains WHY healthcare costs escalate: the system is fighting psychosocially-driven disease with materialist medicine.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- [[specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially]] -- specialization drives both the wealth that triggers the transition and the inequality that makes it pathological
|
||||
- [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]] -- the epidemiological transition explains why healthcare spending grows faster than GDP in developed nations
|
||||
- [[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]] -- treating symptoms of psychosocial disease with pharmaceutical intervention is the epitome of misaligned incentives
|
||||
- [[continuous biometric monitoring transforms healthcare from episodic reaction to predictive prevention]] -- biometrics could address the transition by making psychosocial health visible
|
||||
- [[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]] -- Devoted's model addresses the transition by aligning incentives with actual health improvement
|
||||
- specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially -- specialization drives both the wealth that triggers the transition and the inequality that makes it pathological
|
||||
- healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured -- the epidemiological transition explains why healthcare spending grows faster than GDP in developed nations
|
||||
- US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health -- treating symptoms of psychosocial disease with pharmaceutical intervention is the epitome of misaligned incentives
|
||||
- continuous biometric monitoring transforms healthcare from episodic reaction to predictive prevention -- biometrics could address the transition by making psychosocial health visible
|
||||
- Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them -- Devoted's model addresses the transition by aligning incentives with actual health improvement
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[livingip overview]]
|
||||
- health and wellness
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -9,9 +9,9 @@ confidence: likely
|
|||
|
||||
# the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness
|
||||
|
||||
Healthcare is civilization's largest coordination failure. The US spends $5.3 trillion annually — 18% of GDP, $15,000 per person, 2.5x the OECD average — and gets worse outcomes than every comparable nation. Life expectancy is 2.7 years below the OECD average. Maternal mortality is several times higher than most of Europe. 36% of adults skip or delay care due to cost. The system converts money into health at dramatically lower efficiency than any peer, and since [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]], the trajectory (20.3% of GDP by 2033) threatens to consume resources humanity needs for everything else.
|
||||
Healthcare is civilization's largest coordination failure. The US spends $5.3 trillion annually — 18% of GDP, $15,000 per person, 2.5x the OECD average — and gets worse outcomes than every comparable nation. Life expectancy is 2.7 years below the OECD average. Maternal mortality is several times higher than most of Europe. 36% of adults skip or delay care due to cost. The system converts money into health at dramatically lower efficiency than any peer, and since healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured, the trajectory (20.3% of GDP by 2033) threatens to consume resources humanity needs for everything else.
|
||||
|
||||
This note derives the healthcare attractor state using [[the attractor state derivation template converts human needs and physical constraints into concrete industry direction through iterative analysis that includes built-in challenge and cross-domain synthesis]].
|
||||
This note derives the healthcare attractor state using the attractor state derivation template converts human needs and physical constraints into concrete industry direction through iterative analysis that includes built-in challenge and cross-domain synthesis.
|
||||
|
||||
---
|
||||
|
||||
|
|
@ -48,7 +48,7 @@ Individual needs dominate demand through direct consumer and employer spending.
|
|||
- Administrative overhead: in hospitals alone, admin costs are $687B vs $346B in direct patient care — a **2:1 ratio**. Admin costs are 66.5% of hospital operating expenditures. The US spends $639 per person on healthcare governance and financing — 3x the next highest country and 12x the UK ($53/person).
|
||||
- Estimated waste: $760B-$935B annually (JAMA 2019), with administrative complexity as the largest category at $266B.
|
||||
|
||||
**Incentive architecture — since [[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]]:**
|
||||
**Incentive architecture — since US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health:**
|
||||
|
||||
- **Providers** earn more when people are sick. Fee-for-service pays per procedure, per visit, per test. A healthy patient generates $0 in FFS revenue.
|
||||
- **Insurers** profit from administrative complexity (raises switching costs) and risk selection (avoid the sick, recruit the healthy). MA plans extracted an estimated $40B-$84B annually through coding intensity and favorable selection.
|
||||
|
|
@ -177,11 +177,11 @@ Beyond the three core layers, several additional dimensions may be part of the a
|
|||
|
||||
Healthcare is a **weak attractor** — one of the clearest examples across all industries. There are at least two locally stable configurations:
|
||||
|
||||
**Configuration A: AI-optimized sick-care.** The current system made more efficient with AI. Documentation automated, diagnostics enhanced, workflows streamlined. But the fundamental incentive remains fee-for-service. Hospitals run leaner but the system still treats sickness. This is a local maximum because it's profitable for incumbents and doesn't require coordination across the system. Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9B annual tech spend is being directed at optimizing the current model (consolidating 18 EMRs, AI scribing) rather than rebuilding around prevention. Since [[UnitedHealth and Humana exhibit textbook proxy inertia where coding arbitrage profits rationally prevent pursuit of purpose-built care delivery]], this is rational behavior given their current profit structure.
|
||||
**Configuration A: AI-optimized sick-care.** The current system made more efficient with AI. Documentation automated, diagnostics enhanced, workflows streamlined. But the fundamental incentive remains fee-for-service. Hospitals run leaner but the system still treats sickness. This is a local maximum because it's profitable for incumbents and doesn't require coordination across the system. Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9B annual tech spend is being directed at optimizing the current model (consolidating 18 EMRs, AI scribing) rather than rebuilding around prevention. Since UnitedHealth and Humana exhibit textbook proxy inertia where coding arbitrage profits rationally prevent pursuit of purpose-built care delivery, this is rational behavior given their current profit structure.
|
||||
|
||||
**Configuration B: Prevention-first health maintenance.** The three-layer attractor state described above. More efficient for the system as a whole but requires simultaneous reform of payment, delivery, and technology — a chain-link problem. Since [[excellence in chain-link systems creates durable competitive advantage because a competitor must match every link simultaneously]], once a provider achieves this configuration (Devoted, Kaiser), it creates a durable moat. But reaching it requires crossing a coordination valley that no individual actor can cross alone.
|
||||
**Configuration B: Prevention-first health maintenance.** The three-layer attractor state described above. More efficient for the system as a whole but requires simultaneous reform of payment, delivery, and technology — a chain-link problem. Since excellence in chain-link systems creates durable competitive advantage because a competitor must match every link simultaneously, once a provider achieves this configuration (Devoted, Kaiser), it creates a durable moat. But reaching it requires crossing a coordination valley that no individual actor can cross alone.
|
||||
|
||||
Which configuration the industry converges on depends on regulatory and payment structure decisions being made now. CMS tightening on coding arbitrage pushes toward Configuration B. But if CMS loosens (political change, lobbying), Configuration A could lock in. Since [[economic path dependence means early technological choices compound irreversibly through dominant designs and industrial structures]], the path-dependent choices being made in 2025-2030 will determine the industry's trajectory for decades.
|
||||
Which configuration the industry converges on depends on regulatory and payment structure decisions being made now. CMS tightening on coding arbitrage pushes toward Configuration B. But if CMS loosens (political change, lobbying), Configuration A could lock in. Since economic path dependence means early technological choices compound irreversibly through dominant designs and industrial structures, the path-dependent choices being made in 2025-2030 will determine the industry's trajectory for decades.
|
||||
|
||||
## 5. Challenge and Calibrate
|
||||
|
||||
|
|
@ -249,7 +249,7 @@ Healthcare is primarily individual-need-driven, so demand comes through direct c
|
|||
|
||||
**Energy (Forge domain):** Decentralized energy enables decentralized care delivery. If affordable power reaches rural and underserved areas, telemedicine and AI primary care can operate anywhere. The energy attractor and healthcare attractor are loosely coupled — not dependent but mutually enabling.
|
||||
|
||||
**Space (Astra domain):** Since [[the space manufacturing killer app sequence is pharmaceuticals now ZBLAN fiber in 3-5 years and bioprinted organs in 15-25 years each catalyzing the next tier of orbital infrastructure]], microgravity pharmaceutical manufacturing is the first cross-domain dependency. Superior crystallization in microgravity produces better drug formulations. Orbital pharma is where the space attractor directly serves the healthcare attractor. Bioprinted organs in 15-25 years would transform transplant medicine.
|
||||
**Space (Astra domain):** Since the space manufacturing killer app sequence is pharmaceuticals now ZBLAN fiber in 3-5 years and bioprinted organs in 15-25 years each catalyzing the next tier of orbital infrastructure, microgravity pharmaceutical manufacturing is the first cross-domain dependency. Superior crystallization in microgravity produces better drug formulations. Orbital pharma is where the space attractor directly serves the healthcare attractor. Bioprinted organs in 15-25 years would transform transplant medicine.
|
||||
|
||||
**Entertainment (Clay domain):** Health behavior change is partially a narrative problem. People's health decisions are shaped by cultural narratives about identity, attractiveness, aging, and worth. Since [[social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem]], community and belonging are clinical interventions. Entertainment platforms that build genuine community might be upstream of healthcare outcomes.
|
||||
|
||||
|
|
@ -282,8 +282,8 @@ Healthcare is the clearest case study for TeleoHumanity's thesis: purpose-driven
|
|||
---
|
||||
|
||||
Relevant Notes:
|
||||
- [[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]] -- the structural flaw the attractor state corrects
|
||||
- [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]] -- the civilizational stakes
|
||||
- US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health -- the structural flaw the attractor state corrects
|
||||
- healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured -- the civilizational stakes
|
||||
- [[healthcare AI creates a Jevons paradox because adding capacity to sick care induces more demand for sick care]] -- why AI within the current incentive structure makes things worse, not better
|
||||
- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] -- why the system's products address the wrong 10-20%
|
||||
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] -- the monitoring layer's architecture
|
||||
|
|
@ -299,16 +299,16 @@ Relevant Notes:
|
|||
- [[social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem]] -- loneliness as a clinical condition the system ignores
|
||||
- [[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]] -- where competitive advantage forms within the attractor
|
||||
- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening]] -- the proof of concept for purpose-built payvidor model
|
||||
- [[UnitedHealth and Humana exhibit textbook proxy inertia where coding arbitrage profits rationally prevent pursuit of purpose-built care delivery]] -- incumbent proxy inertia preventing pursuit of the attractor
|
||||
- UnitedHealth and Humana exhibit textbook proxy inertia where coding arbitrage profits rationally prevent pursuit of purpose-built care delivery -- incumbent proxy inertia preventing pursuit of the attractor
|
||||
- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] -- regulatory pressure catalyzing the transition
|
||||
- [[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]] -- the atoms-to-bits defensibility within the attractor
|
||||
- [[the attractor state derivation template converts human needs and physical constraints into concrete industry direction through iterative analysis that includes built-in challenge and cross-domain synthesis]] -- the template used to derive this analysis
|
||||
- [[attractor states for societal-need industries require derived demand channel analysis because civilizational needs lack direct consumer pull and translate through government procurement defense contracts and investor conviction]] -- individual needs dominate but CMS is the critical demand channel for the transition
|
||||
- Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate -- the atoms-to-bits defensibility within the attractor
|
||||
- the attractor state derivation template converts human needs and physical constraints into concrete industry direction through iterative analysis that includes built-in challenge and cross-domain synthesis -- the template used to derive this analysis
|
||||
- attractor states for societal-need industries require derived demand channel analysis because civilizational needs lack direct consumer pull and translate through government procurement defense contracts and investor conviction -- individual needs dominate but CMS is the critical demand channel for the transition
|
||||
- [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] -- the combined signal: attractor identification + proxy inertia of UHC/Humana = strongest thesis
|
||||
- [[disruptors redefine quality rather than competing on the incumbents definition of good]] -- AI primary care disrupts on access and availability, not on traditional physician quality metrics
|
||||
- [[excellence in chain-link systems creates durable competitive advantage because a competitor must match every link simultaneously]] -- once a provider achieves the three-layer configuration, replication requires matching every link
|
||||
- excellence in chain-link systems creates durable competitive advantage because a competitor must match every link simultaneously -- once a provider achieves the three-layer configuration, replication requires matching every link
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- [[attractor dynamics]]
|
||||
- [[livingip overview]]
|
||||
- health and wellness
|
||||
- attractor dynamics
|
||||
- livingip overview
|
||||
|
|
|
|||
|
|
@ -38,9 +38,9 @@ Relevant Notes:
|
|||
- [[gene editing is shifting from ex vivo to in vivo delivery via lipid nanoparticles which will reduce curative therapy costs from millions to hundreds of thousands per treatment]] -- deflationary long-term but front-loaded spending in the transition
|
||||
- [[personalized mRNA cancer vaccines show sustained 49 percent reduction in melanoma recurrence after five years representing a genuinely novel therapeutic paradigm]] -- new cost center from individualized manufacturing
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] -- VBC is designed to bend the cost curve but faces these structural headwinds
|
||||
- [[healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured]] -- the macro consequence of an upward-bending cost curve
|
||||
- healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured -- the macro consequence of an upward-bending cost curve
|
||||
|
||||
- [[launch cost reduction is the keystone variable that unlocks every downstream space industry at specific price thresholds]] -- both healthcare costs and launch costs are keystone variables that gate entire industry ecosystems, but they move in opposite directions (healthcare bends up, launch bends down)
|
||||
- launch cost reduction is the keystone variable that unlocks every downstream space industry at specific price thresholds -- both healthcare costs and launch costs are keystone variables that gate entire industry ecosystems, but they move in opposite directions (healthcare bends up, launch bends down)
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -29,4 +29,4 @@ Relevant Notes:
|
|||
- [[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]] -- mental health is the SDOH domain most affected by the screening-to-action infrastructure gap
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -27,5 +27,5 @@ Relevant Notes:
|
|||
- [[healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software]] -- the AI payment gap may force VBC transition, which would accelerate the physician role shift
|
||||
|
||||
Topics:
|
||||
- [[livingip overview]]
|
||||
- [[health and wellness]]
|
||||
- livingip overview
|
||||
- health and wellness
|
||||
|
|
|
|||
|
|
@ -22,10 +22,10 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
|
|||
Relevant Notes:
|
||||
- [[healthcare is a complex adaptive system requiring simple enabling rules not complicated management because standardized processes erode the clinical autonomy needed for value creation]] -- the systems framework for why payment reform alone fails
|
||||
- [[four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable]] -- the structural models competing to deliver on VBC
|
||||
- [[US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health]] -- the underlying incentive structure that VBC attempts to correct
|
||||
- US healthcare incentives are fundamentally misaligned because every participant profits from sickness not health -- the underlying incentive structure that VBC attempts to correct
|
||||
- [[the physician role shifts from information processor to relationship manager as AI automates documentation triage and evidence synthesis]] -- AI as infrastructure enabling the VBC transition
|
||||
- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]] -- CMS is tightening the FFS-to-VBC transition by closing profitable FFS-like mechanisms within MA, pushing the industry toward genuine risk-bearing
|
||||
- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] -- the 86% of payments not at full risk are systematically ignoring the factors that matter most for health outcomes
|
||||
|
||||
Topics:
|
||||
- [[health and wellness]]
|
||||
- health and wellness
|
||||
|
|
|
|||
Loading…
Reference in a new issue